CHRS
Coherus Biosciences Inc
$2.18
Earnings Summary
Revenue | $91.52Mn |
Net Profits | $-79.65Mn |
Net Profit Margins | -87.03% |
Highlights
Coherus Biosciences Inc’s revenue jumped 101.81% since last year same period to $91.52Mn in the Q4 2023. On a quarterly growth basis, Coherus Biosciences Inc has generated 22.74% jump in its revenue since last 3-months.
Coherus Biosciences Inc’s net profit fell -20.24% since last year same period to $-79.65Mn in the Q4 2023. On a quarterly growth basis, Coherus Biosciences Inc has generated -100.94% fall in its net profits since last 3-months.
Coherus Biosciences Inc’s net profit margin jumped 40.42% since last year same period to -87.03% in the Q4 2023. On a quarterly growth basis, Coherus Biosciences Inc has generated -63.71% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Coherus Biosciences Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.24 |
EPS Estimate Current Year | -0.24 |
Highlights
Coherus Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.24 - a -100% fall from last quarter’s estimates.
Coherus Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.24.
Key Ratios
Key ratios of the Coherus Biosciences Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.62 |
Highlights
Coherus Biosciences Inc’s earning per share (EPS) fell -3.33% since last year same period to -0.62 in the Q4 2023. This indicates that the Coherus Biosciences Inc has generated -3.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-08 | -0.57 | -0.75 | -31.58% |
2023-08-02 | -0.48 | -0.38 | 20.83% |
2024-03-15 | -0.12 | -0.62 | -416.67% |
2023-11-06 | -0.27 | -0.41 | -51.85% |
₹0 US Stocks a/c Opening Fee